Texas Doctors Battle With Podiatrists Over Who Gets The Ankle Mar 20, 2008
The Texas Medical Association argues podiatrists should stick tocorns, calluses and diabetic foot care. The physicians group interprets last Friday's ruling as sayingthe ankle and foot are separate. (KWTX.com, TX)
The story of Mingo Sanders: Fort Missoula Bicycle Corps' most famous member not forgotten Mar 18, 2008
Sanders with his wife settled in Washington, D.C., became a member of the Masonic Lodge, and died in 1929 during a procedure to amputate a gangrenous, diabetic foot. He was buried at Arlington Cemetery. (Missoulian, MT)
Shares in Europe fall back to 2005 levels on Bear Stearns Mar 18, 2008
for ceftobiprole for the treatment of complicated skin and skin structure infections, including diabetic foot infections. The letter means the FDA wants more information being giving the drug its approval. (Yahoo News -- Global Economy)
Cardium Reports on Recent Highlights and Financial Results Mar 15, 2008
(Logo: ) Highlights and Recent Developments -- Initiation of Phase 2b MATRIX clinical trial to evaluate the safety and efficacy of Excellarate(TM) for the potential treatment of non-healing diabetic foot ulcers ... Excellarate(TM) is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. (PR Newswire)
Synthetic Peptoids Hold Forth Promise For New Antibiotics Mar 8, 2008
One type showed promise in the treatment of diabetic foot ulcers. Unfortunately, their applicability has been limited so far to topical use; natural peptides are quickly degraded in the stomach. (Science Daily)
Test Helps Diabetics Detect Nerve Trouble Mar 1, 2008
"The test offers the opportunity to the patients to participate actively in the prevention of the devastating complications related to diabetic foot problems," he added. The IPN turns a pink color when nerve conduction is normal and a blue color when nerve damage is present. (MEDLINEplus)
Lake Pointe Medical Arts Center opens Feb 23, 2008
The most common treatment is diabetic foot ulcers. These chambers can go to three atmospheres, Gibson said. (McKinney Courier-Gazette, TX)
Debut issue of Foot & Ankle Specialist Feb 14, 2008
Features multidisciplinary treatment for diabetic foot infections. An article in the debut issue of SAGEs Foot Specialist (FAS,) written by Thomas Zgonis, DPM, FACFAS, John J. Stapleton, DPM, and Thomas S. Roukis, DPM, FACFAS, details a 3-step treatment plan for patients with diabetic foot infections, recommending first controlling the infection by removing the infected tissue, then conducting a comprehensive assessment, and finally, restructuring the tissue to assure that the wound is closed... (EurekAlert!)
Aastrom Reports Second Quarter Fiscal Year 2008 Financial Results Feb 8, 2008
Interim and final clinical results in the vascular and bone programs: * Promising interim results were presented from the first 13 patients treated in a multi-arm Phase I/II single-center clinical trial in Germany to evaluate the safety of Vascular Repair Cells (VRCs), normal bone marrow cells and the standard of care in the treatment of chronic diabetic foot wounds associated with critical limb ischemia (CLI). Twelve months post-treatment, all patients in the interim analysis who were treated... (Primezone Releases)
Cytomedix Submits Comments in Response to CMS' Proposed National Coverage Decision Jan 30, 2008
In this detailed submission, posted on January 29, 2008, Cytomedix focused its request on chronic wounds and divided them into diabetic foot ulcers and other chronic wounds. The Company introduced new, high quality data that was not considered as part of the PDM and highlighted other evidence not reflected in the preliminary decision. (Primezone Releases)
Orthologic Announces FDA Acceptance of AZX100 IND Application in Dermal/Hypertrophic Scarring; Phase 1 Human Clinical Trial to Begin 1Q2008 Jan 28, 2008
It is being studied in fracture repair, diabetic foot ulcer healing and disorders that involve vascular endothelial dysfunction. The Company owns exclusive worldwide rights to Chrysalin. (Primezone Releases)
Building upon success at KCI Jan 16, 2008
In (a recent) randomized controlled trial which involved 342 patients with diabetic foot ulcers (mostly treated in the home care setting), V.A.C. Therapy healed significantly more wounds, healed them faster and decreased the number of secondary amputations resulting from the ulcer when compared to the control. This is the first study where an advanced wound care therapy technology has demonstrated a limb-salvage benefit in diabetic patients. (San Antonio Business Journal, TX)
Hot feet canwarn oftrouble for diabetics Jan 15, 2008
"They've lost the gift of pain," says Dr. David Armstrong of Chicago's Rosalind Franklin University of Medicine and Science, a diabetic foot specialist ... Treating a simple diabetic foot ulcer can cost $8,000, double that for an infected one and even more for an amputation. (MSNBC -- Health)
Hot Spots Warn of Diabetic Foot Ulcers Jan 15, 2008
Durham, Chapel Hill and the Research Triangle Region. By LAURAN NEERGAARD : AP Medical Writer Jan 14, 2008. (Herald Sun)
SRMC opens new healing center Jan 3, 2008
Diabetic foot wounds are an excellent example of wounds that may benefit most from this type of treatment. Relaxing on a bed encased within a large see-through plastic shell, patients can watch movies on televisions and VCR players mounted above the chamber while hearing the movies and conversing with others outside the chamber through a speaker system. (Lumberton The Robesonian, NC)
Honey Making A Medical Comeback Dec 29, 2007
Dr. Robert Frykberg, chief of podiatry at the Veterans Affairs Medical Center in Phoenix, said the Medihoney product has worked on about half the patients with diabetic foot ulcers who have used it. He said the Medihoney dressing can also prevent the dangerous drug-resistant staph infection known as MRSA from infecting open wounds. (CBS News)
Cytomedix Announces That CMS Preliminarily Affirms Non-Coverage of PRP Gel Dec 21, 2007
The strength of its prospective, well-controlled, double-blinded, randomized clinical trial that shows higher healing rates in diabetic foot ulcers than any other technology including several that are reimbursed by Medicare without having been reviewed nationally in a formal coverage decision ... The unmet need for diabetic foot ulcer and other chronic wound patients who suffer from a lack of advanced treatments with consistent, reliable clinical benefit. (Primezone Releases)
Health departments dietitians now certified to offer diabetes education Dec 19, 2007
In addition the dietitians conduct insulin instruction and group classes on topics ranging from diabetic foot care and nutrition to exercise and medicines, Johnson said. Lipid profile, which is a group of blood tests that determines risk of coronary heart disease, are also taken, she said. (Skieston Standard Democrat, MO)
Surgical implant maker gets $30M in private financing Dec 18, 2007
Innocoll is in the second phase of U.S. testing for two other lead products, a biodegradable collagen-based topical cream for treating diabetic foot infections and ulcers and a second implant geared toward healing post-operative pain. "Having secured the necessary funding, we are well placed to move forward aggressively with the clinical development of our lead pharmaceutical products," President and CEO Michael Myers said in a statement. (Washington Business Journal, DC)
Podiatrists join NMMC-Eupora medical staff Dec 14, 2007
In addition, they have served as clinical instructors of podiatry and have advanced training in diabetic foot care. The podiatrists offer the latest procedures and protocols to relieve pain; correct bunions and hammertoes; repair fractures, injuries, structural problems and deformities; and treat neurological, vascular and limb-threatening conditions. (Webster Progress-Times, MS)
'Superbug' Infections More Than Doubled In Hospitals, Study Finds Dec 7, 2007
19, 2004) A clinical trial involving 371 patients in eight countries shows that linezolid, a new antibiotic, is at least as effective as two older therapies for treating diabetic foot infections. The drug may. (Science Daily)
Oculus fills up clinical trial for foot ulcer treatment Dec 6, 2007
has enrolled 67 patients in a Phase II clinical trial of a treatment for diabetic foot ulcers that have become infected. The Petaluma company (NASDAQ: OCLS) seeks to develop treatments for infections in chronic and acute wounds. (San Francisco Business Journal)
More of this story Nov 21, 2007
The report noted that the wound care clinic in the outpatient area, which specializes in wounds that are difficult to heal such as pressure sore and diabetic foot ulcers, opened October 19. The clinic is treating about eight patients per week. (Hamburg Ashley County Ledger, AR)
Diabetes count: Three crore patients in India now Nov 14, 2007
Dr SK Gupta, Reader in General Surgery Department, spoke about diabetic foot. Foot ulcers are very common in diabetic patients. (Hindustan Times)
Almost Two-thirds of Diabetics Risk Amputation Nov 14, 2007
And the World Health Organization has said that the number of people suffering from diabetes could double to 366 million by 2030 and that 80 per cent of diabetic foot amputations could be prevented. A hundred patients aged 24 to 89 volunteered to take part in the shoe-size study carried out at a general diabetic clinic at Ninewells Hospital Medical School in Dundee, Scotland. (Newsmax)
Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2008 Financial Results Nov 9, 2007
75) one year post-BRC treatment - 100% of the patients who have healed are fully weight-bearing, have regained range of motion and are no longer impaired by their injuries - Severe bone fracture results supported bone regeneration proof of principle and the initiation of Aastrom's U.S. Phase III osteonecrosis of the femoral head clinical trial -- Encouraging interim results from two German research groups utilizing Aastrom's proprietary Tissue Repair Cell (TRC) Technology platform to manufacture... (Primezone Releases)
Genaera licenses rights to frog-derived diabetic foot-ulcer cream Oct 22, 2007
Genaera developed a synthetic version, formulated it as a cream and developed it as a potential treatment for patients with infected diabetic foot ulcers. This article is for Paid Print Subscribers ONLY.. (Philadelphia Business Journal, PA)
Left to their own devices: Biotech hogs spotlight, but medical machine-makers endure Oct 21, 2007
From left, Iyia Technologies President and Chief Executive Officer Raymond Huggenberger, founder and Chief Operating Officer Adrian Pelkus, and Vice President of Engineering Ray Ryland look at the company s O2Misly, which delivers pure oxygen alternating with an antibiotic mist to speed healing of diabetic foot ulcers ... The tiny company, with just three employees, is preparing to start manufacturing and sales of a device to speed healing of diabetic foot ulcers ... The company has clinically... (North County Times)
Scared Off Silicone Oct 16, 2007
A diabetic foot ulcer and its attendant complications constitute a surer death sentence than colorectal cancer just over half of all diagnosed patients survive for five years. More startling than these statistics, however, is that for 40 years, physicians have known about a safe medical procedure to prevent these ulcers. (Scientific American)
Cytomedix Submits Cost Effectiveness Study For AutoloGel to CMS Oct 8, 2007
Oct. 8, 2007 (PRIME NEWSWIRE) -- Cytomedix, Inc. (AMEX: - ) today announced that it has submitted, to the Centers for Medicare and Medicaid Services (CMS), a cost effectiveness analysis of AutoloGel(tm) as compared to certain alternative therapies for patients with diabetic foot ulcers ... This model developed by B&D simulates the clinical, cost, and quality-adjusted life years (QALYs) outcomes associated with using the AutoloGel(tm) System versus certain other treatment modalities in treating... (Primezone Releases)
Genaera sells rights to drug it didn't have resources to develop Oct 4, 2007
Genaera, then known as Magainin Pharmaceuticals, developed the substance into a cream for use as a potential treatment for patients with infected diabetic foot ulcers. The Food and Drug administration rejected Genaera's new drug application for the drug, known as Locilex, in 1999. (Philadelphia Business Journal, PA)
Aastrom Announces Positive Interim Results From Phase I/II Study Involving Use of Vascular Repair Cells in Patients With Critical Limb Ischemia Oct 4, 2007
The first study reported positive results from the use of Aastrom Vascular Repair Cells (VRCs) in the treatment of chronic diabetic foot wounds associated with critical limb ischemia (CLI) ... In an oral presentation, Dr. Bernd Stratmann of the Diabetes Center at the Heart and Diabetes Center in North Rhine-Westphalia (Center), Bad Oeynhausen, Germany, presented interim results from the first 13 patients treated in a multi-arm Phase I/II single-center clinical trial to evaluate the safety of... (Primezone Releases)
‘Limb-salvage teams' fight amputations from common diabetic foot sores Oct 4, 2007
Limb-salvage teams' fight amputations from common diabetic foot sores ... Treating a simple diabetic foot ulcer can cost 8,000; an infected one, 17,000. (Leesville Daily Leader, LA)
Limb-salvage teams help save diabetics feet Oct 2, 2007
Treating a simple diabetic foot ulcer can cost $8,000; an infected one, $17,000. The main message for the average diabetic: Take off your socks and shoes at every visit to the doctor and ask that he or she examine your feet. (MSNBC -- Health)
CytRx to Present at ThinkEquity Partners 5 th Annual Growth ... Sep 15, 2007
The Company has also announced plans to commence a Phase II clinical trial with its next drug candidate, iroxanadine, for diabetic foot ulcers in the first half of 2008, subject to FDA clearance. CytRx has recently opened a research and development facility in San Diego. (Business Wire (press release), CA)
OrthoLogic to Present At the First Albany Capital Regenerative Technologies Conference Sep 7, 2007
Chrysalin, the Company's novel synthetic 23-amino acid peptide, is being studied in several indications including fracture repair, diabetic foot ulcer healing and other disorders that may involve vascular endothelial dysfunction. The Company owns exclusive worldwide rights to Chrysalin. (Primezone Releases)
Diabetic Foot Disease Aug 18, 2007
What are things that could happen with a diabetic foot ... Living With Diabetic Foot ... Lipsky, Benjamin A., et al. "Diagnosis and Treatment of Diabetic Foot Infections." Clinical Infectious Diseases 39. (Suite101.com)
TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP) Aug 10, 2007
Nemonoxacin, an once-a-day oral and IV antibacterial active against gram-positive and -negative pathogens and MRSA, will soon to enroll diabetic foot infection patients in a double-blind phase 2 trial. The company has first-in-class phase 1-ready drug candidates for treating critical limb ischemia and retinopathy/age-related macular degeneracy, and advanced preclinical candidates for chronic Hepatitis C virus infection and cancer. (PR Newswire)
Benefits of New Wound Therapy Questioned Aug 9, 2007
"There is no compelling evidence," they add, "that topical negative pressure helps skin graft 'take,' or the healing of pressure ulcers or simple diabetic foot ulcers.". Adverse effects of the device, Ikeanacho noted, could include damage to the wound, and pain. (MEDLINEplus)
Topical Negative Pressure For Chronic Wounds? Aug 4, 2007
VAC Therapy has been used for various different types of wound, including bed sores (pressure ulcers), diabetic foot ulcers, venous ulcers, and skin grafts ... For example, "there is no compelling evidence" that it helps bed sores or uncomplicated diabetic foot ulcers heal more quickly or that it aids skin grafts to 'take,' says DTB.. (Science Daily)
Canton trying to find new site for growing biotech company Aug 2, 2007
The product, which uses human donor cells, is used primarily to treat venous leg ulcers and diabetic foot ulcers, ailments that can lead to amputations or even death. O'Reilly declined to comment on other possible locations, but said that staying in Canton is a priority because about 80 percent of the company's employees lives within 10 miles. (Boston Globe -- Business)
Program slated on "diabetic foot" Jul 31, 2007
Diabetic foot problems can be very painful, slow-healing and expensive, but some of those problems can be prevented, a press release from OSF Saint James-John W. Albrecht Medical Center said. In her presentation, "The Diabetic Foot and Complications," Dr. Deloris Rizqallah, podiatrist, will explain all aspects of diabetes foot care and preventative measures in a program Tuesday, Aug. 7, at 7 p.m. The meeting will be held in the first floor conference room of the hospital. (Pontiac Daily Leader, IL)
University picks Hardy for medical school post Jul 23, 2007
Founded to serve the city's Latino community, the student groups were asked to assemble 15 kits for child, prenatal or diabetic foot care needs. The ECU group provided 26 kits: 10 diabetic foot care kits, nine prenatal kits and seven child kits. (The Daily Reflector)
Valuable 'Footcare Health Tips' Booklet Now Available from Microplane Jul 20, 2007
The booklet contains valuable information from Dr. Brenner, founder and Chief of the Institute of Diabetic Foot Research, and past president of the American Society of Podiatric Dermatology, about how to practice proper foot care. Helpful information contained in the booklet includes: - Preventable health issues that can be detected (and reversed. (Yahoo News -- Press Releases)
Macrochem acquires option to license pexiganan Jul 11, 2007
Pexiganan is a novel topical anti-infective for treatment of diabetic foot infection ... July 10 /PRNewswire-FirstCall/ -- MacroChem Corporation (OTCBB: MACM - News) today announced that it has signed an exclusive option to acquire exclusive worldwide license rights for drug uses of pexiganan, a novel, small peptide anti-infective for topical treatment of patients with mild diabetic foot infection (DFI), from Genaera Corporation (Genaera) ... Mr. DeLuccia further noted, "We would be pleased to... (EurekAlert! -- Business News)
Growth far short of estimates Jun 1, 2007
Proceeds will be used for marketing for Dermagraft, approved by the Food and Drug Administration as a treatment for diabetic foot ulcers. Sponsored Links. (San Diego Union-Tribune -- Business)
Kinetic Concepts: High Tech Healing May 30, 2007
A company-sponsored study released in May involving 335 patients found that VAC was able to close more diabetic foot ulcers and close them faster than traditional therapy. That lowered the number of foot amputations in the Kinetic group to 7, compared with 17 in the control group. (BusinessWeek)
Firm makes 'healing super-water' May 24, 2007
It is also effective against MRSA and UK trials are being carried out on patients with diabetic foot ulcers, New Scientist magazine reported ... About 15% of diabetic foot ulcers result in amputation. (BBC News)
Fronteer Announces $60.5 Million Underwritten Marketed Deal In Canada May 18, 2007
Excellarate is initially being developed to be administered once or twice for the potential treatment of non-healing diabetic foot ulcers. Other potential applications for TRC's Gene Activated Matrix(TM) (GAM) technology include therapeutic angiogenesis (cardiovascular ischemia, peripheral arterial disease) and orthopedic products, including hard tissue (bone) and soft tissue (ligament, tendon, cartilage) repair. (Investors Business Daily)
Maggots Rid Patients Of Antibiotic-resistant Infection, MRSA May 6, 2007
"Professor Boulton and his team, including senior nurse Ann Knowles, have used maggots to treat diabetic foot ulcers of patients attending the Manchester Diabetes Centre and foot clinics, as well as in in-patients at the Manchester Royal Infirmary, for ten years. More recently they found that many of their patients were suffering from MRSA-contaminated foot ulcers, with the rate doubling in a three year period, possibly due to overuse of antibiotics and the selection of broad rather than... (Science Daily)
UW study tests topical honey as a treatment for diabetic ulcers May 4, 2007
Currently, every 30 seconds someone somewhere in the world undergoes amputation for a diabetic foot ulcer. In 2001, treating diabetic ulcers and amputations in U.S. patients cost $10. (EurekAlert!)
Maggots feast on MRSA, researchers find May 3, 2007
"He said: "We have demonstrated for the first time the potential of larval therapy to eliminate MRSA infection of diabetic foot ulcers. "If confirmed in a randomised controlled trial, larval treatment would offer the first non-invasive and risk-free treatment of this increasing problem and a safe and cost-effective treatment, in contrast to the expensive and potentially toxic antibiotic remedies.". (Guardian Unlimited)
KCI's wound-healing technology may be a defense against diabetic foot ulcers May 2, 2007
The medical technology company also found that because V.A.C. Therapy aided in the healing of diabetic foot ulcers, it reduced the incidence of foot amputations, according to KCI officials. This clinical trial involved 335 investigational subjects with complex, hard-to-heal diabetic foot ulcers across 37 centers in the United States ... KCI officials say this is the first large multi-center, randomized, controlled clinical trial to examine V.A.C. Therapy for the treatment of diabetic foot-ulcer... (San Antonio Business Journal, TX)
Support group to help those affected by diabetes Apr 15, 2007
Johnson, a registered nurse at Greenwood Leflore Hospital and a diabetic foot specialist, teaches about the disease. A diabetic herself, she knows its effects well. (Greenwood Commonwealth, MS)
Fiona Nelson Mar 18, 2007
"It can also be used externally to help treat a burn, wound, amputation-stump wound, ulcer, diabetic leg ulcer, diabetic foot ulcer, sore, bedsore, pressure sore, decubitus, decubitus ulcer, scar, Methicillin-resistant staph aureus, infected wound or surgical scar-wound healing." It may even alleviate acne and fungal infections. Nelson also sells Organic Autumn Forest Honeydew (OAFH) honey that bees create from sap they collect from beech trees in the mountain-based rain forests of New Zealand's... (Wayne Suburban Newspapers, PA)
Wright Medical Group will demonstrate product in Web cast Mar 16, 2007
Graftjacket is designed primarily for diabetic foot ulcers and provides the body with a scaffold on which to build new tissue. Wright (NASDAQ: WMGI) is based in Arlington and employs more than 600 people. (Memphis Business Journal, TN)
Singapore conclave suggests amputation prevention progress being made, worldwide Mar 16, 2007
"This was a rather important meeting," noted Professor David G. Armstrong of Scholls Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University of Medicine and Science in North Chicago who, along with Dr. Stephan Morbach, President of the European Association for the Study of Diabetes Diabetic Foot Study Group, presented one of two keynote addresses to the gathering. "The data shown here seem to be suggesting that diabetic foot clinics are having an impact on... (EurekAlert!)
Investment to come in handy for foot treatment Feb 28, 2007
intends to use the money to finish launching and expand the market for Dermagraft, which has been approved by the for treatment of diabetic foot ulcers. As part of the transaction, Safeguard's (NYSE:SFE) vice president for life sciences, Dr. Gary J. Kurtzman, has joined ABH's board of directors. (Philadelphia Business Journal, PA)
Scholl's Armstrong in Spain keynote: 'Amputations worse than cancer' Feb 23, 2007
Keynote at the Spanish National Symposium on the Diabetic Foot raises crucial questions and offers workshops on new technologies. The Spanish National Symposium on the Diabetic Foot last week was the scene for a keynote address that delivered a strong message proposing "a marriage of technology with common sense for the next decade." The address was delivered by David G. Armstrong, DPM, PhD, Professor of Surgery and Associate Dean at Scholl College at Rosalind Franklin University. (EurekAlert!)
Medical notes Feb 21, 2007
Care of the Diabetic Foot -- 7-8 p.m., Dunlap Memorial Hospital, 832 S. Main St., Orrville. Free. (Akron Beacon Journal, OH -- Living)
Hospitals to provide better patient care with recruitment of more nurses Feb 18, 2007
Sunday February 18, 2:17 PM. Hospitals are looking forward to recruiting more nurses, following the announcement of an additional 4,500 nurses to the workforce, to cater to healthcare needs. (Channel NewsAsia, Singapore)
Ugly Toenails May Be Fungal Infection in Diabetics Feb 14, 2007
Doctors "should be alert to our finding that, in patients at high risk for developing diabetic foot ulcerations, fungal infections of the toenails are common," Dr. Stephanie Wu, from Rosalind Franklin University of Medicine and Science in North Chicago, told Reuters Health. Wu also emphasized that just because a nail is thickened and discolored does not mean that there is a fungal infection. (MEDLINEplus)
Community News Feb 13, 2007
There will be a free health screening Tuesday at Gerrity s Supermarket in the Hanover Mall from 10 a.m. to 2 p.m. The event will include blood pressure and cholesterol screening, blood sugar check, breath and strength evaluations and diabetic foot care education. Also, take your medications with you and Mercy Special Care pharmacists will answer any questions you might have about dosage, side affects and more. (The Citizen's Voice, PA)
Basilea Reports 2006 Financial Results Jan 31, 2007
And in 2007, the announcement of second pivotal phase III study results for the treatment of complicated skin infections and infections in diabetic foot patients including Gram-negative pathogens showing high clinical cure rates, good safety and tolerability. Isavuconazole (BAL8557) - Broad-spectrum Antifungal Agent. (Primezone Releases)
Simple classification can help define and predict limb-threatening diabetic infections Jan 31, 2007
Research groups from Texas, Chicago, Washington State and the Netherlands partnered to publish a landmark study validating the Infectious Disease Society of America's guidelines for the clinical classification of diabetic foot infections. "We're all very pleased to see this study in print," noted co-author David G. Armstrong, DPM, PhD, Professor of Surgery at Scholl's Center for Lower Extremity Ambulatory Research (CLEAR) at Rosalind Franklin University. (EurekAlert!)
